Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 36, Pages 14771-14776
Publisher
Proceedings of the National Academy of Sciences
Online
2013-08-20
DOI
10.1073/pnas.1302212110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Risks of Copper Toxicity Contributing to Cognitive Decline in the Aging Population and to Alzheimer's Disease
- (2013) George J. Brewer JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease
- (2012) George J. Brewer BIOFACTORS
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease
- (2012) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- Copper dysfunction in Alzheimer's disease: From meta-analysis of biochemical studies to new insight into genetics
- (2012) Rosanna Squitti JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- A neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors
- (2012) H. You et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated labile Cu is associated with oxidative pathology in Alzheimer disease
- (2011) Simon A. James et al. FREE RADICAL BIOLOGY AND MEDICINE
- Presenilins Promote the Cellular Uptake of Copper and Zinc and Maintain Copper Chaperone of SOD1-dependent Copper/Zinc Superoxide Dismutase Activity
- (2011) Mark A. Greenough et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroinflammatory and behavioural changes in the Atp7B mutant mouse model of Wilson’s disease
- (2011) Dick Terwel et al. JOURNAL OF NEUROCHEMISTRY
- The Alzheimer’s therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity
- (2011) Peter J. Crouch et al. JOURNAL OF NEUROCHEMISTRY
- Mechanism of copper(II)-induced misfolding of Parkinson's disease protein
- (2011) Frisco Rose et al. Scientific Reports
- Copper handling machinery of the brain
- (2010) Svetlana Lutsenko et al. Metallomics
- Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease
- (2009) R. Deane et al. CNS & Neurological Disorders-Drug Targets
- Paradoxical Condensation of Copper with Elevated β-Amyloid in Lipid Rafts under Cellular Copper Deficiency Conditions
- (2009) Ya Hui Hung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Copper transport to the brain by the blood-brain barrier and blood-CSF barrier
- (2008) Byung-Sun Choi et al. BRAIN RESEARCH
- apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
- (2008) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
- (2008) Berislav V. Zlokovic NEURON
- Therapeutics for Alzheimer’s disease based on the metal hypothesis
- (2008) Ashley I. Bush et al. Neurotherapeutics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now